Established in 2019, IMsystem Co., Ltd. has developed Korea’s first micro medical robot system for precision vascular interventional procedures, and is currently commercializing it.
Currently, IMsystem has completed the prototype production of a remote magnetic micro medical robot system for vascular intervention procedures, and the licensing process is in progress.

Micro medical robot system for precision vascular intervention procedures
Unlike existing vascular intervention procedures in which the operator manually manipulates surgical tools, the micro medical robot system for precision vascular intervention (IM_SuperMag_Clinic) uses a magnetic field control system installed at the bottom of the patient’s bed. It is a remote surgery system using a magnetic guide wire/catheter microrobot attached to a microrobot fitted at the end of the existing guide wire/catheter.

Existing procedures have limitations in that it is difficult to insert surgical tools into narrow blood vessels of complex shapes due to manual manipulation by the operator, so the results of the treatment depend on the operator’s skill level. In addition, in the case of complex procedures, not only does exposure to radiation from X-rays, etc., increase due to increased procedure time, but the number of patients who can receive the procedure is also limited due to operator fatigue.
IM_SuperMag_Clinic controls remote surgical tools through magnetic field control, and the operator performs the procedure using a joystick/3D mouse while viewing X-ray images in a separate space rather than inside the operating room.

By reducing fatigue and radiation exposure and improving the convenience of the procedure, the success rate of the procedure, the speed of patient recovery, and the number of daily patients can be increased. It can thus meet the needs of patients, operators, and hospitals, respectively.
Following the completion of prototype development has been completed, and domestic GMP and licensing are currently in preparation. The acquisition of a domestic license is expected by the end of 2025. For overseas, IMsystem is aiming for CE and FDA approval in 2028. And it is expected that it will be able to quickly advance into overseas markets after being exempted from clinical trials by receiving 510k equivalent recognition from the FDA. 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods